Compounds > n-hydroxy-n--(4-butyl-2-methylphenyl)formamidine

n-hydroxy-n--(4-butyl-2-methylphenyl)formamidine and Diabetes-Mellitus--Type-1

n-hydroxy-n--(4-butyl-2-methylphenyl)formamidine has been researched along with Diabetes-Mellitus--Type-1* in 1 studies

Other Studies

1 other study(ies) available for n-hydroxy-n--(4-butyl-2-methylphenyl)formamidine and Diabetes-Mellitus--Type-1

ArticleYear
Hyperbaric oxygenation and 20-hydroxyeicosatetreanoic acid inhibition reduce stroke volume in female diabetic Sprague-Dawley rats.
    Experimental physiology, 2017, 12-01, Volume: 102, Issue:12

    What is the central question of this study? Is there a beneficial effect and what are the mechanisms of acute and multiple hyperbaric oxygenation (HBO

    Topics: Amidines; Animals; Aryl Hydrocarbon Hydroxylases; Brain; Combined Modality Therapy; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Cytochrome P450 Family 4; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Epoxide Hydrolases; Female; Gene Expression Regulation, Enzymologic; Hydroxyeicosatetraenoic Acids; Hyperbaric Oxygenation; Infarction, Middle Cerebral Artery; Neuroprotective Agents; Nitric Oxide Synthase Type III; Rats, Sprague-Dawley; Reperfusion Injury; RNA, Messenger; Steroid 16-alpha-Hydroxylase; Time Factors

2017